Skip to main content
. Author manuscript; available in PMC: 2022 Nov 16.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2021 Nov 16;14(11):e007847. doi: 10.1161/CIRCOUTCOMES.121.007847

Table 5:

Prevalence of Echocardiographic Abnormalities in Total Study Sample

Total (n=155) Male (n=52) Female (n=103)
Systolic Function N (%) N (%) N (%) p-value
 EF, mean in % (±SD) 58.3 (±8.6) 57.6 (±8.4) 58.7 (±8.6) 1
 EF <40% 5 (3.3) [1.1–7.4] 1 (1.9) [0.1–10.3] 4 (3.9) [1.1–9.7] 0.48*
 EF 41–49% 11 (7.1) [3.6–12.3] 6 (11.5) [4.4–23.4] 5 (4.9) [1.6–11.0]
 EF ≥50% 138 (89.6) [83.8–94.0] 45 (29.2) [17.1–43.1] 93 (60.4) [50.1–69.7]
Diastolic Function N (%) N (%) N (%) p-value
 Normal Diastolic Function 2 (1.3) [0.2–4.6] 1 (1.9) [0.1–10.3] 1 (1.0) [0.03–5.3] 0.87**
 Mild Diastolic Dysfunction 65 (41.9) [34.1–50.1] 21 (40.4) [27.0–54.9] 44 (42.7) [33.0–52.9]
 Moderate Diastolic Dysfunction 48 (31.0) [23.8–38.9] 11 (21.2) [11.1–34.7] 37 (35.9) [26.7–46.0]
 Severe Diastolic Dysfunction 40 (25.8) [19.1–33.4] 19 (36.5) [23.6–51.0] 21 (20.4) [13.1–29.5]
Left Ventricular Indices in Diastole N (%) N (%) N (%) p-value
 Concentric Hypertrophy 49 (31.6) [24.4–40.0] 7 (13.5) [5.6–25.8] 42 (40.8) [31.2–51.0] 0.0001
 Eccentric Hypertrophy 23 (14.8) [9.6–21.4] 5 (9.6) [3.2–21.0] 18 (17.5) [10.7–26.2] 0.19
 RWT, mean (±SD) 0.49 (±0.10) 0.46 (±0.10) 0.50 (±0.10) 0.098
  Normal RWT 55 (35.5) [28.0–43.6] 24 (46.2) [32.2–60.5] 31 (30.1) [21.5–39.9] 0.048
  High RWT 100 (64.5) [56.4–72.0] 28 (18.1) [8.2–30.3] 72 (69.9) [60.1–78.6]
 IVSd, mean in mm (±SD) 10.97 (±2.2) 10.50(±2.2) 11.20 (±2.1) 0.055
  Normal IVSd 49 (31.6) [24.4–40.0] 26 (50.0) [35.8–64.2] 23 (22.3) [35.8–64.2] 0.0005
  High IVSd 106 (68.4) [60.4–75.6] 26 (50.0) [35.8–64.2] 80 (77.7) [68.4–85.3]
 PWd, mean in mm (±SD) 10.4 (±1.8) 10.2 (±2.0) 10.5 (±10.2) 0.26
  Normal PWd 63 (40.7) [32.8–48.8] 32 (61.5) [47.0–74.7] 31 (30.1) [21.5–39.9] 0.0002
  High PWd 92 (59.4) [51.2–67.2] 20 (38.5) [25.3–53.0] 72 (69.9) [25.3–53.0]
 LVM, mean in g (±SD) 163.9 (±42.0) 165.2 (±46.5) 163.2 (±39.8) 0.78
  Normal LVM 83 (53.6) [45.4–61.6] 40 (76.9) [63.2–87.5] 43 (41.8) [32.1–51.9] <0.0001
  High LVM 72 (46.5) [38.4–54.6] 12 (23.1) [12.5–36.8] 60 (58.4) [48.1–67.9]
 LVMi, mean in g/m2 (±SD) 90.9 (±21.1) 93.3 (±23.2) 89.6 (±19.9) 0.31
  Normal LVMi 84 (54.2) [46.0–62.2] 33 (63.5) [49.0–76.4] 51 (49.5) [40.0–59.5] 0.10
  High LVMi 71 (45.8) [37.8–54.0] 19 (36.5) [23.6–51.0] 52 (50.5) [40.5–60.5]
Right Ventricle Parameters N (%) N (%) N (%) p-value
 PASP, mean in mm Hg (±SD) 22.8 (±6.6) 22.3 (±7.2) 23.0 (±6.4) 0.65
  Normal PASP 151 (97.4) [93.5–99.3] 50 (96.2) [86.8–99.5] 101 (98.1) [93.2–99.8] 0.60
  High PASP 4 (2.6) [0.07–6.5] 2 (3.9) [0.05–13.2] 2 (1.9) [0.2–6.8]
Valvular Pathologies N (%) N (%) N (%) p-value
 AR (moderate, severe) 3 (1.9) [0.04–5.6] 1 (1.9) [0.05–10.3] 2 (1.9) [0.2–6.8] 1
 No AR (including trace and mild) 152 (98.1) [94.4–99.6] 51 (98.1) [89.7– 99.9] 101 (98.1) [93.2–99.8]
 MR (moderate, severe) 3 (1.9) [0.4–5.6] 0 (0) [0–0] 3 (2.9) [0.6–8.3] 0.55
 No MR (including trace and mild) 152 (98.1) [94.4–99.6] 52 (100) [98.7–100] 100 (97.1) 91.7–99.4]
 MS (trace, mild, moderate, severe) 10 (6.5) [3.1–11.5] 5 (9.6) [3.2– 21.0] 5 (4.9) [1.6–11.0] 0.30
 No MS 145 (93.6) [88.5–96.9] 47 (90.4) [79.0–96.8] 98 (95.2) [89.0–98.4]
 TR (moderate, severe) 5 (3.2) [1.1–7.4] 0 (0) [0–0] 5 (4.9) [1.6–11.0] 0.17
 No TR (including trace and mild) 150 (96.8) [92.6–98.9] 52 (100) [98.9–100] 98 (95.2) [89.0–98.4]
 PR (moderate, severe) 1 (0.7) [0.02–3.5] 0 (0) [0–0] 1 (1.0) [0.03– 5.3] 1
 No PR (including trace and mild) 154 (99.4) [96.5–99.9] 52 (33.6) [20.3–47.1] 102 (99.0) [94.7–99.9]

EF, ejection fraction; TTE, transthoracic echocardiogram; RWT, relative wall thickness; IVSd, interventricular septum diameter; PWd, posterior wall diameter; LVM/LVMi, left ventricular mass/index; PASP, pulmonary artery systolic pressure; RV, right ventricle; AR, aortic regurgitation; MR, mitral regurgitation; MS, mitral stenosis; TR, tricuspid regurgitation; PR, pulmonary regurgitation.

*

This Chi-square test compared EF<40% and EF 41–49% (as a composite variable) versus EF ≥50%.

**

This Chi-square test compared normal diastolic function and mild diastolic dysfunction (as a composite variable) versus moderate and severe diastolic dysfunction (as a composite variable).